Better Monitoring of Cisplatin-Induced Ototoxicity Needed
More than half of patients treated with cisplatin develop hearing impairment, but there are few guidelines on the monitoring, prevention, and management of ototoxicity.
Medscape Medical News
source https://www.medscape.com/viewarticle/991347?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/991347?src=rss
Comments
Post a Comment